2443 — Lead Data Income Statement
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
Annual income statement for Lead Data, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.
2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 210 | 22.7 | 21 | 15.5 | 111 |
| Cost of Revenue | |||||
| Gross Profit | -21.1 | -21.7 | -6.47 | -9.27 | -27.8 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 342 | 116 | 307 | 156 | 169 |
| Operating Profit | -131 | -93 | -285 | -140 | -57.9 |
| Total Net Non Operating Interest Income / Expense | |||||
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -110 | 86.2 | -210 | -136 | -48.7 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -110 | 86.2 | -211 | -136 | -48.8 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -106 | 87.5 | -194 | -134 | -44 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | -106 | 87.5 | -194 | -134 | -44 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.713 | 0.289 | -0.567 | -0.568 | -0.292 |
| Dividends per Share |